Monday, July 15, 2013

Testimonial Review Stemtech AFA Extract

Testimonial Review Stemtech AFA Extract
Testimonial Review Stemtech AFA Extract. For many years people talked about the benefits of the algae AFA, but there was no good science and no understanding about what AFA was doing. Dr Gitte Jensen and Christian Drapeau were the first to propose that AFA was influencing stem cells. They have a patent for the purification of the AFA extract and for showing the increase in stem cell production when people take the extract orally. StemTech is the beneficiary of that work.

Research was needed to find out how to isolate to active part of AFA and to concentrate it. It was discovered that AFA contains a blocker of l-selectin (which encourages the bone marrow to release stem cells) and polysaccharides (that help stem cells enter body tissues).

First Patent: An Extract from AFA increases the number of Stem Cells in the blood.

A double blind, small group, placebo controlled, crossover study, confirmed that StemEnhance™ is effective at supporting the release of stem cells from the bone marrow, increasing the number of circulating stem cells by up to 30%. (Remember StemEnhance™ was the old product, SE2™, is for most people, even more effective.)

The New England Journal of Medicine, published a study suggesting that the number of circulating stem cells has a direct correlation to overall heart health (September 8, 2005, 353(10): 999-1007).

Second Patent: Oral Capsules of StemEnhance™ provide an effective dose.

In 2007, StemTech announced the availability of StemEnhance™. - StemEnhance™ is an extract developed from the freshwater algae Aphanizomenon flos-aquae, commonly called AFA.

StemEnhance™ has been shown to support and increase naturally-occurring Bone Marrow Stem Cell release, within normal ranges. This is the bodies own natural process for maintaining and rebuilding the body from the inside. AFA is put through an extraction process from that took 5 years to perfect, and guarantees the quality of every StemEnhance™ capsule. StemTech has two patents based on the processing of AFA, and the delivery of an effective dose of the extract to people via oral capsules.
In 2011, StemTech announced the availability of SE2™. - SE2™ delivers the benefits of StemEnhance™ plus some additional ability to extend the activity of stem cells in the bloodstream. SE2™ contains four ingredients. The extract from AFA, plus Fucoidan an extract from Undaria Pinnatifida, an extract from Polygonum multiflorum, and Cordyceps Sinensis a mushroom long used in Chinese medicine. Some people are allergic to Cordyceps Sinensis, and find that StemEnhance™ is the more satisfactory product.

The method of extracting Fucoidan from the brown seaweed Undaria Pinnatifida, is patented, by Marinova Pty. Ltd in Tasmania. StemTech have the exclusive world wide rights to this technology.

No comments:

Post a Comment